Avita Medical Stock
Avita Medical Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Devices
- Country
- United States
- CEO
- Cary G. Vance
- Employees
- 226
- Market cap
- $324 M
- IPO
- 14/05/2012
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and…
Avita Medical stock: price history
1D
-2.8%
1W
-1.3%
1M
+24.8%
6M
+153.7%
YTD
+278.0%
1Y
+142.4%
2Y
+22.0%
5Y
-24.9%
10Y
+44.9%
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~74% stronger price swings than usual
Ask the agents about Avita Medical
Analyst assessment of Avita Medical
PRICE TARGET LOW
US$11.00
CONSENSUS
US$11.50
MEDIAN
US$11.50
PRICE TARGET HIGH
US$12.00
0
STRONG BUY
7
BUY
1
HOLD
0
SELL
0
STRONG SELL
8
TOTAL · Buy
As of: 12/10/2026
Avita Medical stock metrics
P/E
-8.99
P/B
-14.4
EV/EBITDA
-10.33
RETURN ON EQUITY
27.5%
NET MARGIN
-35.3%
DEBT/EQUITY
-1.74
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
96.2%
FLOAT SHARES
23,889,826
AVG. DAILY VOLUME (30D)
323,004
Insider transactions (SEC)
O'Toole David D
Woody Joseph Fralin
Woody Joseph Fralin
Woody Joseph Fralin
Woody Joseph Fralin
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Avita Medical stock
What does Avita Medical do?
Avita Medical Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is Cary G. Vance, the company employs around 226 people.
The IPO was on 14/05/2012; the stock trades on NASDAQ under the ticker RCEL.
What do analysts say about Avita Medical stock?
8 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
The average price target is US$11.50, ranging from US$11.00 to US$12.00, with a median of US$11.50.
This is an external assessment, not a statement by Market Jury.
When does Avita Medical report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 74% stronger than usual.
Does Avita Medical pay a dividend?
No, Avita Medical currently does not pay a dividend.
Which stocks are comparable to Avita Medical?
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
How can I get Avita Medical stock analyzed?
Clicking "Analyze stock" lets five strategies assess Avita Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.